MPG.eBooks - Table of Contents: Second-line therapy for patients with relapsing-remitting multiple sclerosis

Read Now

Second-line therapy for patients with relapsing-remitting multiple sclerosis a review of guidelines

There is uncertainty in clinical practice regarding how and when to switch from the first-line therapy to a second-line therapy for relapsing-remitting multiple sclerosis (RRMS). This review seeks to report on the critically appraisal of the evidence-based guidelines regarding switching to a second-...

Full description

Bibliographic Details
Main Authors:	Li, Ke Xin, Picheca, Lory (Author)
Corporate Authors:	Canadian Agency for Drugs and Technologies in Health, Canadian Agency for Drugs and Technologies in Health Rapid Response Service
Format:	eBook
Language:	English
Published:	Ottawa (ON) CADTH 2019, September 26, 2019
Series:	CADTH rapid response report: summary with critical appraisal
Subjects:	Multiple Sclerosis, Relapsing-remitting / Drug Therapy Immunologic Factors / Therapeutic Use Antineoplastic Agents, Immunological / Therapeutic Use Treatment Outcome Immunosuppressive Agents / Therapeutic Use Practice Guidelines As Topic
Online Access:	https://www.ncbi.nlm.nih.gov/books/NBK549531
Collection:	National Center for Biotechnology Information - Collection details see MPG.ReNa

Table of Contents:

Includes bibliographical references

Second-line therapy for patients with relapsing-remitting multiple sclerosis a review of guidelines

Similar Items